These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 26031595

  • 1. Treatment of acute antibody-mediated rejection using bortezomib: a case report.
    Sin YH, Kim YJ, Oh JS, Lee JH, Kim SM, Kim JK.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014 Jul; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

  • 3. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
    Sadaka B, Ejaz NS, Shields AR, Cardi MA, Wadih G, Witte D, Abu Jawdeh BG, Alloway RR, Woodle ES.
    Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
    [Abstract] [Full Text] [Related]

  • 4. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
    Niikura T, Yamamoto I, Nakada Y, Kamejima S, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():75-8. PubMed ID: 26031592
    [Abstract] [Full Text] [Related]

  • 5. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
    Fujimoto T, Nakada Y, Yamamoto I, Kobayashi A, Tanno Y, Yamada H, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():81-5. PubMed ID: 26031594
    [Abstract] [Full Text] [Related]

  • 6. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report.
    Takamura T, Yamamoto I, Nakada Y, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():70-4. PubMed ID: 26031591
    [Abstract] [Full Text] [Related]

  • 7. Bortezomib-based treatment of acute antibody-mediated rejection: a case report.
    Wang Q, Li XL, Xu XG, Shi BY, Zhang ZM, Li ZL, Han Y, Zhou WQ, Chen CQ, Cai M, Zhang X.
    Genet Mol Res; 2015 Dec 22; 14(4):17951-8. PubMed ID: 26782441
    [Abstract] [Full Text] [Related]

  • 8. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
    De Sousa-Amorim E, Revuelta I, Diekmann F, Cofan F, Lozano M, Cid J, Palou E, Sole M, Campistol JM, Oppenheimer F.
    Nephrology (Carlton); 2016 Aug 22; 21(8):700-4. PubMed ID: 26492594
    [Abstract] [Full Text] [Related]

  • 9. The impact of C4d staining as a humoral injury marker.
    Kara M, Demir F, Ata P, Ozel L, Gumrukcu G, Unal E, Canbakan M, Gucun M, Esadoglu V, Ozdemir E, Cemel H, Titiz MI.
    Transplant Proc; 2012 Aug 22; 44(6):1694-6. PubMed ID: 22841245
    [Abstract] [Full Text] [Related]

  • 10. Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection
.
    Ding Y, Francis J, Gautam A, Pelletier L, Sanchorawala V, Quillen K.
    Clin Nephrol; 2018 Apr 22; 89(4):252-259. PubMed ID: 29208204
    [Abstract] [Full Text] [Related]

  • 11. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
    Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar N.
    Transplantation; 2014 Jun 27; 97(12):1240-6. PubMed ID: 24937198
    [Abstract] [Full Text] [Related]

  • 12. The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: report of three cases and review of literature.
    Tzvetanov I, Spaggiari M, Joseph J, Jeon H, Thielke J, Oberholzer J, Benedetti E.
    Transplant Proc; 2012 Dec 27; 44(10):2971-5. PubMed ID: 23195008
    [Abstract] [Full Text] [Related]

  • 13. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL, Murillo D.
    Clin Transpl; 2011 Dec 27; ():401-8. PubMed ID: 22755438
    [Abstract] [Full Text] [Related]

  • 14. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
    Matsuo N, Yamamoto H, Kobayashi A, Yamamoto I, Mitome J, Maruyama Y, Hayakawa H, Miyazaki Y, Utsunomiya Y, Hosoya T, Yamaguchi Y.
    Clin Transplant; 2009 Aug 27; 23 Suppl 20():23-6. PubMed ID: 19594591
    [Abstract] [Full Text] [Related]

  • 15. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial.
    Eskandary F, Bond G, Schwaiger E, Kikic Z, Winzer C, Wahrmann M, Marinova L, Haslacher H, Regele H, Oberbauer R, Böhmig GA.
    Trials; 2014 Apr 03; 15():107. PubMed ID: 24708575
    [Abstract] [Full Text] [Related]

  • 16. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES.
    Transplantation; 2010 Feb 15; 89(3):277-84. PubMed ID: 20145517
    [Abstract] [Full Text] [Related]

  • 17. Case presentations on two patients who received bortezomib for antibody mediated rejection at BIDMC.
    Pavlakis M.
    Clin Transpl; 2009 Feb 15; ():343-5. PubMed ID: 20524296
    [Abstract] [Full Text] [Related]

  • 18. Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.
    Schwaiger E, Regele H, Wahrmann M, Werzowa J, Haidbauer B, Schmidt A, Böhmig GA.
    Clin Transpl; 2010 Feb 15; ():391-6. PubMed ID: 21696056
    [Abstract] [Full Text] [Related]

  • 19. Antibody-mediated rejection and treatment in pediatric patients: one center's experience.
    Gulleroglu K, Baskin E, Bayrakci US, Turan M, Ozdemir BH, Moray G, Karakayali H, Haberal M.
    Exp Clin Transplant; 2013 Oct 15; 11(5):404-7. PubMed ID: 24128133
    [Abstract] [Full Text] [Related]

  • 20. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
    Sureshkumar KK, Hussain SM, Marcus RJ, Ko TY, Khan AS, Tom K, Vivas CA, Parris G, Jasnosz KM, Thai NL.
    Clin Nephrol; 2012 Mar 15; 77(3):246-53. PubMed ID: 22377258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.